GEROLD BEPLER, MD, PhD, President and Chief Executive Officer of the Barbara Ann Karmanos Cancer Institute, has been elected to serve a 3-year term on the Association of American Cancer Institutes (AACI) Board of Directors. AACI comprises 97 leading cancer research centers in North America and is dedicated to reducing the burden of cancer by enhancing the impact of these leading academic cancer centers.
“I am honored and pleased to be elected to the AACI Board of Directors that represents elite cancer centers across the country,” Dr. Bepler said. “I look forward to collaborating with fellow board members to help cancer experts advance this nation’s cancer care.”
An element of AACI’s mission is to assist the centers in keeping pace with the changing landscape in science, technology, and health care. It does so by gathering and sharing best practices among cancer centers; providing a forum for members to address common challenges and explore new opportunities; and supporting initiatives that engage the membership in developing specific recommendations.
Host of Accomplishments
IN ADDITION TO leading the Karmanos Cancer Institute headquartered in Detroit, Dr. Bepler is a world-renowned thoracic oncologist who has spent his career researching risks, disease progression, treatments, and outcomes related to lung cancer.
He is credited with creating the Karmanos Cancer Network, Michigan’s largest cancer care and research network, with 14 locations throughout the state. Karmanos is 1 of only 49 National Cancer Institute–designated comprehensive cancer centers in the United States.
Dr. Bepler also serves as Chair of the Department of Oncology at Wayne State University School of Medicine in Detroit and is principal investigator of the National Cancer Institute Comprehensive Cancer Center Support Grant. Dr. Bepler is a member of the Women’s Choice Healthcare Advisory Board with WomenCertified Inc. (2014–present) and was nominated and elected in 2012 to the internationally prestigious Fleischner Society for Thoracic Imaging and Diagnosis. ■